SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents

IMPORTANCE: Reports of myocarditis after SARS-CoV-2 messenger RNA (mRNA) vaccination have emerged. OBJECTIVE: To evaluate the risks of myocarditis and pericarditis following SARS-CoV-2 vaccination by vaccine product, vaccination dose number, sex, and age. DESIGN, SETTING, AND PARTICIPANTS: Four coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlstad, Øystein, Hovi, Petteri, Husby, Anders, Härkänen, Tommi, Selmer, Randi Marie, Pihlström, Nicklas, Hansen, Jørgen Vinsløv, Nohynek, Hanna, Gunnes, Nina, Sundström, Anders, Wohlfahrt, Jan, Nieminen, Tuomo A., Grünewald, Maria, Gulseth, Hanne Løvdal, Hviid, Anders, Ljung, Rickard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021987/
https://www.ncbi.nlm.nih.gov/pubmed/35442390
http://dx.doi.org/10.1001/jamacardio.2022.0583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021987/
https://www.ncbi.nlm.nih.gov/pubmed/35442390
http://dx.doi.org/10.1001/jamacardio.2022.0583

Ejemplares similares